Showing results (171-180 of 189) with videos related to
Sort By:
Pageof 19
International Journal of Clinical Oncology|April 22, 2024
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022Tetsuhiro Yoshinami, Kazuki Nozawa, Takamichi Yokoe, et al.International Journal of Clinical Oncology|February 11, 2025
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022Takamichi Yokoe, Tetsuhiro Yoshinami, Kazuki Nozawa, et al.International Journal of Clinical Oncology|March 25, 2024
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022Yukinori Ozaki, Takamichi Yokoe, Tetsuhiro Yoshinami, et al.International Journal of Clinical Oncology|April 5, 2024
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical OncologyMamoru Ito, Yuta Okumura, Kenta Nio, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 6, 2022
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma modelKyoko Yamaguchi, Tomoyasu Yoshihiro, Hiroshi Ariyama, et al.Clinical Colorectal Cancer|August 29, 2018
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal CancerKenji Tsuchihashi, Mamoru Ito, Toshikazu Moriwaki, et al.International Journal of Clinical Oncology|March 22, 2024
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022Keita Uchino, Shingo Tamura, Shoji Kimura, et al.International Journal of Clinical Oncology|February 14, 2024
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022Eiki Ichihara, Nobuaki Ochi, Go Makimoto, et al.International Journal of Clinical Oncology|March 28, 2024
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022Shoji Kimura, Keisuke Shigeta, Shingo Tamura, et al.The Oncologist|November 15, 2018
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal CancerYoshihiko Fujita, Masataka Taguri, Kentaro Yamazaki, et al.Pageof 19